Valuation: Sysmex Corporation

Market Cap 985B 6.06B 5.3B 4.9B 4.5B 8.51B 584B 8.66B 58.47B 22.97B 285B 22.78B 22.28B P/E 2027 *
23.2x
P/E 2028 * 19.2x
Enterprise Value 989B 6.09B 5.32B 4.92B 4.52B 8.55B 587B 8.7B 58.71B 23.06B 287B 22.87B 22.37B EV / Sales 2027 *
1.85x
EV / Sales 2028 * 1.74x
Free-Float
72.3%
Yield 2027 *
2.41%
Yield 2028 * 2.54%
1 day+4.96%
1 week+6.34%
Current month+10.71%
1 month+14.29%
3 months+13.29%
6 months+3.14%
Current year+5.54%
1 week 1,527
Extreme 1527
1,631.5
1 month 1,353
Extreme 1353
1,631.5
Current year 1,246
Extreme 1246
1,631.5
1 year 1,246
Extreme 1246
2,563.5
3 years 1,246
Extreme 1246
3,243
5 years 1,246
Extreme 1246
5,241.67
10 years 1,246
Extreme 1246
5,241.67
Manager TitleAgeSince
Chief Executive Officer 76 01/04/2018
Director of Finance/CFO 56 -
President 65 01/04/2026
Director TitleAgeSince
Chairman 76 01/04/2013
Director/Board Member 67 01/06/2014
Director/Board Member 68 01/06/2014
Change 5-day change 1-year change 3-year change Capi.($)
+4.96%+6.34%-34.62%-47.64% 5.78B
+2.09%+8.16%-15.70%-5.06% 172B
+0.50%+0.58%-5.77%-2.71% 107B
+1.18%+3.26%+6.44%+63.07% 59.92B
+0.87%+7.20%-9.96%-36.53% 44.07B
-1.22%+0.32% - - 34.76B
-1.25%+3.54%-7.72%-43.54% 30.09B
-0.18%+2.79%+64.08%-5.22% 25.61B
+0.05%+2.24%-2.85%-18.20% 20.86B
-0.52%+2.85%-1.08%-2.71% 21.55B
Average +0.68%+3.17%-0.80%-10.95% 52.17B
Weighted average by Cap. +0.92%+3.35%-4.62%-2.36%

Financials

2027 *2028 *
Net sales 535B 3.29B 2.88B 2.66B 2.44B 4.62B 317B 4.7B 31.73B 12.47B 155B 12.36B 12.09B 566B 3.48B 3.04B 2.81B 2.58B 4.89B 336B 4.97B 33.57B 13.19B 164B 13.08B 12.79B
Net income 41.08B 253M 221M 204M 188M 355M 24.37B 361M 2.44B 958M 11.9B 950M 929M 49.5B 305M 266M 246M 226M 428M 29.36B 435M 2.94B 1.15B 14.34B 1.14B 1.12B
Net Debt 4.07B 25.03M 21.88M 20.23M 18.57M 35.14M 2.41B 35.75M 241M 94.79M 1.18B 94M 91.93M 713M 4.39M 3.84M 3.55M 3.26M 6.16M 423M 6.27M 42.31M 16.62M 207M 16.48M 16.12M
Logo Sysmex Corporation
Sysmex Corp is a Japan-based company principally engaged in the health care business. The Company conducts product development, manufacturing, sales, and service in domestic markets, and some products are developed, manufactured, and sold by subsidiaries. Overseas, the Company conducts the manufacturing and sales of products in the Americas, EMEA, China, and Asia Pacific through other companies. Along with its subsidiaries, the Company is involved in the development, manufacture, sale and service of clinical laboratory equipment, laboratory test drugs and products related to laboratory test.
Employees
10,861
Date Price Change Volume
17/07/26 JP¥1,628.00 +4.96% 5,271,100
16/07/26 JP¥1,551.00 +0.65% 1,966,900
15/07/26 JP¥1,541.00 -1.28% 1,716,400
14/07/26 JP¥1,561.00 +0.61% 1,993,600
13/07/26 JP¥1,551.50 +1.34% 1,868,900
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
1,551.00JPY
Average target price
1,719.33JPY
Spread / Average Target
+10.85%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6869 Stock